Mirovsky Pavel

Avg. Two Year Performance

No purchase track record

93% Avg. Sale Return

39% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	4%	4%	54%	66%	93%
Sale Success Rate	3 of 3	3 of 3	2 of 3	2 of 3	3 of 3

Valeant Pharmaceuticals Int...

Drugs » Drug Delivery

EVP, Pres. & GM Valeant EMENA:

Holdings: 69.53K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--